NO20051561L - Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. - Google Patents

Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.

Info

Publication number: NO20051561L
Authority: NO; Norway
Prior art keywords: nucleic acid; acid molecules; human papillomavirus; molecules encoding; vaccine
Prior art date: 2002-10-03

Application number

NO20051561A

Other languages

English (en)

Norwegian (no)

Other versions

NO20051561D0 (no

Inventor

Gerald Wayne Gough

Christopher Michael Roberts

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-03

Filing date

2005-03-23

Publication date

2005-06-02

2005-03-23 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-03-23 Publication of NO20051561D0 publication Critical patent/NO20051561D0/no

2005-06-02 Publication of NO20051561L publication Critical patent/NO20051561L/no

Links

150000007523 nucleic acids Chemical class 0.000 title abstract 2
102000039446 nucleic acids Human genes 0.000 title abstract 2
108020004707 nucleic acids Proteins 0.000 title abstract 2
241000701806 Human papillomavirus Species 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1
238000000034 method Methods 0.000 abstract 2
239000013598 vector Substances 0.000 abstract 2
108010041986 DNA Vaccines Proteins 0.000 abstract 1
229940021995 DNA vaccine Drugs 0.000 abstract 1
208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Plant Pathology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20051561A 2002-10-03 2005-03-23 Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. NO20051561L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0222953.2A GB0222953D0 (en)	2002-10-03	2002-10-03	Novel Compounds
PCT/EP2003/011158 WO2004031222A2 (en)	2002-10-03	2003-10-01	Dna vaccine encoding at least two nonstructural early proteins of papillomavirus

Publications (2)

Publication Number	Publication Date
NO20051561D0 NO20051561D0 (no)	2005-03-23
NO20051561L true NO20051561L (no)	2005-06-02

Family

ID=9945247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20051561A NO20051561L (no)	2002-10-03	2005-03-23	Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.

Country Status (21)

Country	Link
US (2)	US20060165713A1 (is)
EP (1)	EP1546191A2 (is)
JP (1)	JP2006516386A (is)
KR (1)	KR20050050115A (is)
CN (1)	CN100393878C (is)
AR (1)	AR041515A1 (is)
AU (1)	AU2003294672A1 (is)
BR (1)	BR0314986A (is)
CA (1)	CA2500093A1 (is)
CO (1)	CO5580837A2 (is)
GB (1)	GB0222953D0 (is)
IS (1)	IS7775A (is)
MA (1)	MA27474A1 (is)
MX (1)	MXPA05003558A (is)
NO (1)	NO20051561L (is)
NZ (1)	NZ539154A (is)
PL (1)	PL376534A1 (is)
RU (1)	RU2354701C2 (is)
TW (1)	TW200411055A (is)
WO (1)	WO2004031222A2 (is)
ZA (1)	ZA200503201B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ540098A (en)	2002-10-29	2008-09-26	Coley Pharmaceutical Group Ltd	Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
CL2008000249A1 (es) *	2007-01-30	2008-05-30	Transgene Sa	Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus
GB0710538D0 (en) *	2007-06-01	2007-07-11	Glaxo Group Ltd	Vaccine
WO2011161244A1 (en) *	2010-06-25	2011-12-29	Vaccibody As	Homodimeric protein constructs
CA2965498A1 (en) *	2014-10-24	2016-04-28	Hpvvax, Llc.	Compositions and uses of a papilloma virus (hpv) vaccine for the treatment of hpv related cancer and skin lesions
JP2019505512A (ja)	2016-01-08	2019-02-28	バッシボディアクスイェセルスカプ	治療用抗癌ネオエピトープワクチン
CA3023022A1 (en) *	2016-05-04	2017-11-09	Transgene Sa	Combination therapy with cpg tlr9 ligand
WO2021205027A1 (en)	2020-04-09	2021-10-14	Vaccibody As	Individualized therapeutic anticancer vaccine
CA3197920A1 (en) *	2020-11-25	2022-06-02	Douglas E. Brough	Human papilloma virus vaccines and uses of the same for hpv associated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPN443995A0 (en) *	1995-07-27	1995-08-17	Csl Limited	Papillomavirus polyprotein
GB0017990D0 (en) *	2000-07-21	2000-09-13	Glaxo Group Ltd	Papilloma virus sequences
NZ523683A (en) *	2000-07-21	2004-08-27	Glaxo Group Ltd	Codon-optimized papilloma virus sequences

2002
- 2002-10-03 GB GBGB0222953.2A patent/GB0222953D0/en not_active Ceased
2003
- 2003-10-01 MX MXPA05003558A patent/MXPA05003558A/es not_active Application Discontinuation
- 2003-10-01 AU AU2003294672A patent/AU2003294672A1/en not_active Abandoned
- 2003-10-01 CN CNB2003801049852A patent/CN100393878C/zh not_active Expired - Fee Related
- 2003-10-01 KR KR1020057005806A patent/KR20050050115A/ko not_active Abandoned
- 2003-10-01 BR BR0314986-2A patent/BR0314986A/pt not_active IP Right Cessation
- 2003-10-01 TW TW092127210A patent/TW200411055A/zh unknown
- 2003-10-01 EP EP03785608A patent/EP1546191A2/en not_active Withdrawn
- 2003-10-01 CA CA002500093A patent/CA2500093A1/en not_active Abandoned
- 2003-10-01 RU RU2005109155/13A patent/RU2354701C2/ru not_active IP Right Cessation
- 2003-10-01 JP JP2004540797A patent/JP2006516386A/ja active Pending
- 2003-10-01 NZ NZ539154A patent/NZ539154A/en unknown
- 2003-10-01 PL PL376534A patent/PL376534A1/pl not_active Application Discontinuation
- 2003-10-01 WO PCT/EP2003/011158 patent/WO2004031222A2/en not_active Ceased
- 2003-10-01 US US10/529,931 patent/US20060165713A1/en not_active Abandoned
- 2003-10-03 AR ARP030103608A patent/AR041515A1/es unknown
2005
- 2005-03-23 NO NO20051561A patent/NO20051561L/no not_active Application Discontinuation
- 2005-03-29 IS IS7775A patent/IS7775A/is unknown
- 2005-04-15 MA MA28223A patent/MA27474A1/fr unknown
- 2005-04-20 ZA ZA200503201A patent/ZA200503201B/en unknown
- 2005-04-28 CO CO05040562A patent/CO5580837A2/es not_active Application Discontinuation
2007
- 2007-06-08 US US11/760,127 patent/US20070264283A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004031222A2 (en)	2004-04-15
RU2005109155A (ru)	2006-03-10
NZ539154A (en)	2007-05-31
KR20050050115A (ko)	2005-05-27
IS7775A (is)	2005-03-29
CO5580837A2 (es)	2005-11-30
CA2500093A1 (en)	2004-04-15
AR041515A1 (es)	2005-05-18
ZA200503201B (en)	2006-06-28
CN1720261A (zh)	2006-01-11
JP2006516386A (ja)	2006-07-06
MA27474A1 (fr)	2005-08-01
TW200411055A (en)	2004-07-01
AU2003294672A1 (en)	2004-04-23
US20070264283A1 (en)	2007-11-15
CN100393878C (zh)	2008-06-11
RU2354701C2 (ru)	2009-05-10
EP1546191A2 (en)	2005-06-29
GB0222953D0 (en)	2002-11-13
US20060165713A1 (en)	2006-07-27
WO2004031222A3 (en)	2004-08-19
BR0314986A (pt)	2005-08-09
NO20051561D0 (no)	2005-03-23
PL376534A1 (pl)	2006-01-09
MXPA05003558A (es)	2005-06-03

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
BR112021024786A2 (pt)	2022-02-22	Construção de rna, sequência de ácido nucleico, cassete de expressão, vetor recombinante, composição farmacêutica, método para preparar a construção de rna, vacina, método para modificar uma célula ex vivo ou in vitro e célula modificada
NO20064584L (no)	2006-10-10	Tetrahydropyridoindolderivater
NO20050795L (no)	2005-04-12	Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
BRPI0510428A (pt)	2007-10-30	composições tópicas de metadona e processos para utilização das mesmas
MX362981B (es)	2019-02-28	Moleculas artificiales de acido nucleico para la expresion mejorada de proteina o peptido.
MY140840A (en)	2010-01-29	Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
AU2002248384A1 (en)	2002-08-06	Serpin drugs for treatment of hiv infection and method of use thereof
NO20073059L (no)	2007-07-19	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NZ543467A (en)	2008-07-31	The severe acute respiratory syndrome coronavirus
NO20054185D0 (no)	2005-09-09	Methods of radiofluorination of biologically active vectors
NO20064347L (no)	2006-09-26	Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20055832L (no)	2006-02-03	Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme
HUP0401534A2 (hu)	2004-11-29	Módosított humán IX. faktor
NO20052071L (no)	2005-05-23	Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
MX2009008118A (es)	2009-10-13	Polipeptido e2 del virus del papiloma usado para vacunacion.
MX2009004243A (es)	2009-05-14	Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
NO20052136L (no)	2005-07-11	Vaksine mot Hepatitt C-virus (HCV).
WO2022192594A3 (en)	2022-11-24	Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
PL1962815T3 (pl)	2011-02-28	Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
NO20055624L (no)	2005-11-29	Tropanderivater og deres anvendelse som Ace-inhibitorer
WO2009037183A3 (de)	2009-06-11	Nukleinsäurehaltige kosmetische und/oder pharmazeutische zubereitung zur induktion antimikrobieller peptide in epithelialen deckgeweben
WO2002078631A3 (en)	2004-01-29	Improved conditionally replicating vectors for inhibiting viral infections
NO983090L (no)	1998-09-01	Terapeutiske forbindelser
WO2004031222A3 (en)	2004-08-19	Dna vaccine encoding at least two nonstructural early proteins of papillomavirus
DE60325838D1 (de)	2009-03-05	Imidazoquinolinamine als adjuvantien für hiv dna vakzine